Linda Duska Selected Research

Linda Duska Research Topics

9	Neoplasms (Cancer) 08/2023 - 01/2006
7	Endometrial Neoplasms (Endometrial Cancer) 01/2024 - 01/2016
5	Disease Progression 01/2024 - 01/2006
4	Carcinoma (Carcinomatosis) 11/2013 - 03/2010
4	Ovarian Neoplasms (Ovarian Cancer) 11/2013 - 01/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 06/2009
3	Microsatellite Instability 01/2023 - 05/2012
2	Adenocarcinoma 12/2023 - 06/2009
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2023 - 01/2015
2	Diarrhea 01/2022 - 11/2013
2	Neoplasm Metastasis (Metastasis) 11/2019 - 11/2013
1	Adenosquamous Carcinoma 12/2023
1	Fever (Fevers) 12/2023
1	Arthralgia (Joint Pain) 12/2023
1	Exanthema (Rash) 12/2023
1	Carcinosarcoma 01/2022
1	Granulosa Cell Tumor 01/2019
1	Uterine Neoplasms (Uterine Cancer) 05/2015
1	Dehydration (Water Stress) 11/2013
1	Ovarian Epithelial Carcinoma 11/2013
1	Endometrioid Carcinoma 05/2012
1	Peritoneal Neoplasms 03/2010
1	Fatigue 08/2009
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 08/2009

6	PlatinumIBA 12/2023 - 01/2006
2	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 11/2013
2	dostarlimabIBA 08/2023 - 01/2022
2	Estrogen ReceptorsIBA 01/2019 - 01/2019
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2019
1	pembrolizumabIBA 01/2024
1	lenvatinibIBA 01/2024
1	Bevacizumab (Avastin)FDA Link 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	atezolizumabIBA 12/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	cabozantinibIBA 01/2022
1	NivolumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	EnzymesIBA 01/2022
1	LigandsIBA 01/2020
1	Aligeron (AS 2)IBA 11/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	liposomal doxorubicin (Doxil)FDA Link 11/2013
1	etirinotecan pegolIBA 11/2013
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2013
1	Peptides (Polypeptides)IBA 11/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2013
1	Indicators and Reagents (Reagents)IBA 11/2013
1	Cyclin D1IBA 05/2012
1	Melanocyte-Stimulating Hormones (MSH)IBA 05/2012
1	CateninsIBA 05/2012
1	Drug CombinationsIBA 01/2012
1	taxaneIBA 01/2012
1	AlbuminsIBA 03/2010

7	Therapeutics 01/2024 - 01/2006
5	Drug Therapy (Chemotherapy) 01/2024 - 01/2012
2	Immunotherapy 01/2022 - 01/2020
1	Radiotherapy 01/2016
1	Hysterectomy 05/2015
1	Chemoradiotherapy 01/2015
1	Brachytherapy 01/2015
1	Aftercare (After-Treatment) 11/2013
1	Adjuvant Chemotherapy 01/2012
1	Lymph Node Excision (Lymph Node Dissection) 06/2009
1	Surgical Amputation (Amputations) 06/2009
1	Trachelectomy 06/2009
1	Complementary Therapies (Alternative Medicine) 01/2006